Navigation Links
Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in the U.S. Senate
Date:6/27/2012

harmaceuticals with financial, scientific and clinical support from the Cystic Fibrosis Foundation.  Kalydeco's swift approval, announced by the FDA just three months after it was submitted for review, demonstrates how a well-informed, collaborative FDA review process involving reviewers, industry partners, patients and cystic fibrosis experts can efficiently move lifesaving therapies to market.  Kalydeco is the first CF drug to address the underlying cause of the disease in select CF patient groups.

About the Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more cystic fibrosis research than any other organization, and nearly every CF drug available today was made possible because of Foundation support. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. The Cystic Fibrosis Foundation is a donor-supported nonprofit organization. For more information, go to www.cff.org.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Icahn Issues Statement Regarding Amylin Pharmaceuticals
2. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
3. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
4. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
5. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
6. Lilly Statement on PDUFA Vote by Senate
7. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
8. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
9. Top-line Data From Phase 3 Trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis Show Promising Results
10. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
11. Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a preliminary prospectus supplement to its effective shelf registration statement ... with securities regulatory authorities in each of the provinces of ... offering of its common shares to raise gross proceeds of ... also grant to the underwriters of the Offering an option, ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... Two months ago, Suyima Torres, 28, died from ... session of a silicone treatment for gluteus augmentation at Cuerpos ... performed by a mystery Venezuelan doctor in a center that ... Bernabe Vazquez of Bayshore Cosmetic Surgery , women suffering ... are not board certified is more common than people think. ...
(Date:6/18/2013)... Calif. (PRWEB) June 18, 2013 David ... professor of Family Medicine for the College of Osteopathic ... Health Sciences has been elected president of the ... Edmund G. Brown Jr. appointed Connett, a 1984 alumnus ... OMBC members recently elected Connett to the position during ...
(Date:6/18/2013)... People with HIV are more likely to keep their ... if they feel their physician listens, explains things ... a "case," new Johns Hopkins research suggests. , "If ... to them, they feel that doctor has their best ... follow medical advice," says study leader Tabor E. Flickinger, ...
(Date:6/18/2013)... of investigators co-led by Weill Cornell Medical College is ... research, similar to the kind of risk and benefit ... no dynamic research framework to systematically detect devices and ... may even be harmful," says co-lead investigator Dr. Art ... the June 18 issue of the British Medical ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Respect may be the key to stopping patient 'no shows' 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
... ... SRI International, an independent nonprofit research and development institute, announced ... its Center for Health Sciences. This new SRI group of neuroscientists and ... of funding from the National Institutes of Health (NIH), including the ...
... , LAVAL, QC and ... Inc. (TSX: DDS; NASDAQ: DDSS ) today announced the closing ... units were sold at a price of US$1.70 per ... were US$18,150,000 after deducting underwriting discounts and commissions, and ...
... how human genes interact with their environment to boost ... edition of the American Journal of Human Genetics ... for specific gene variants linked to human diseases can ... genes and environmental factors influence common human diseases like ...
... the battlefield, a new UCLA study of U.S. Civil War ... units characterized by a strong esprit de corps were much ... heart condition than veterans from less cohesive companies, two UCLA ... expect your buddy to have your back," said Dora Kosta, ...
... ... of IT Infrastructure , ... Reston, VA (PRWEB) February 18, 2010 -- Carahsoft Technology Corp. , the trusted ... provider of extreme-scale grid computing software and services. Carahsoft is placing Parabon ...
... ... team, names Estelle Cummings as Area Vice-President of Sales , ... Cambridge, MD (PRWEB) February 18, 2010 -- ... V.P. of Sales for the CCBsure®, technology program . Cummings oversees new ...
Cached Medicine News:Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 2Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 3Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 4Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 5Health News:SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program 6Health News:Labopharm announces closing of US$20 million public offering of units 2Health News:Labopharm announces closing of US$20 million public offering of units 3Health News:UCLA study reveals how genes interact with their environment to cause disease 2Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 2Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 3Health News:Battlefield camaraderie yields long-term dividends for veterans, study finds 4Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 3Health News:CCBsure Names New Area Vice-President of Sales 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: